Trimebutine Promotes Glioma Cell Apoptosis as a Potential Anti-tumor Agent

Gliomas are the most common primary brain tumors with a usually fatal malignancy. They are associated with a poor prognosis although multiple therapeutic options have been available. Trimebutine is one of the prokinetic agents and it has been mainly used for treatment of disorders of the gastrointes...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yi-pu, Liu, Pei, Xue, Wei-kang, Zhao, Wei-jiang, Pan, Hong-chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021541/
https://www.ncbi.nlm.nih.gov/pubmed/29977208
http://dx.doi.org/10.3389/fphar.2018.00664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021541/
https://www.ncbi.nlm.nih.gov/pubmed/29977208
http://dx.doi.org/10.3389/fphar.2018.00664

Ejemplares similares